Search

Your search keyword '"Ikeda, Uichi"' showing total 1,385 results
Start Over Author "Ikeda, Uichi"
1,385 results on '"Ikeda, Uichi"'

2. Prognostic ability of mid-term worsening renal function after percutaneous coronary intervention: findings from the SHINANO registry

Author

Okina, Yoshiteru, Miura, Takashi, Senda, Keisuke, Taki, Minami, Kobayashi, Masanori, Kanai, Masafumi, Okuma, Yukari, Yanagisawa, Takashi, Hashizume, Naoto, Otagiri, Kyuhachi, Shoin, Kyoko, Watanabe, Noboru, Ebisawa, Soichiro, Karube, Kenichi, Nakajima, Hiroyuki, Saigusa, Tatsuya, Miyashita, Yusuke, Kashiwagi, Daisuke, Machida, Keisuke, Abe, Naoyuki, Tachibana, Takahiro, Kanzaki, Yusuke, Maruyama, Takuya, Nomi, Hidetomo, Sakai, Takahiro, Yui, Hisanori, Mochidome, Tomoaki, Kobayashi, Takahiro, Kasai, Toshio, Ikeda, Uichi, and Kuwahara, Koichiro

Published
2021
Full Text
View/download PDF

3. Impact of Low Bone Mineral Content Index on Cardiovascular Outcomes in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

Author

Itagaki, Tadashi, primary, Ueki, Yasushi, additional, Sunohara, Daisuke, additional, Aoki, Moeko, additional, Nomoto, Fumika, additional, Takamatsu, Toshifumi, additional, Mochidome, Tomoaki, additional, Miura, Takashi, additional, Kasai, Toshio, additional, Kuwahara, Koichiro, additional, and Ikeda, Uichi, additional

Published
2024
Full Text
View/download PDF

7. Validation and Comparison of the Prognosis Predicting Ability of Inflammation-Based Scores Following Endovascular Treatment for Peripheral Artery Disease

Author

Itagaki, Tadashi, primary, Ebisawa, Soichiro, additional, Kato, Tamon, additional, Miura, Takashi, additional, Oyama, Yushi, additional, Hashizume, Naoto, additional, Yokota, Daisuke, additional, Taki, Minami, additional, Senda, Keisuke, additional, Okina, Yoshiteru, additional, Wakabayashi, Tadamasa, additional, Fujimori, Kouki, additional, Karube, Kenichi, additional, Sakai, Takahiro, additional, Nomoto, Fumika, additional, Takamatsu, Toshifumi, additional, Tanaka, Kiu, additional, Mochidome, Tomoaki, additional, Saigusa, Tatsuya, additional, Motoki, Hirohiko, additional, Kasai, Toshio, additional, Ikeda, Uichi, additional, and Kuwahara, Koichiro, additional

Published
2023
Full Text
View/download PDF

9. Clinical impact of complete revascularization in elderly patients with multi-vessel coronary artery disease undergoing percutaneous coronary intervention: A sub-analysis of the SHINANO registry

Author

Harada, Mikiko, Miura, Takashi, Kobayashi, Takahiro, Kobayashi, Hideki, Kobayashi, Masanori, Nakajima, Hiroyuki, Kimura, Hikaru, Akanuma, Hiroshi, Mawatari, Eiichiro, Sato, Toshio, Hotta, Shoji, Kamiyoshi, Yuichi, Maruyama, Takuya, Watanabe, Noboru, Eisawa, Takayuki, Hashizume, Naoto, Ebisawa, Soichiro, Miyashita, Yusuke, and Ikeda, Uichi

Published
2017
Full Text
View/download PDF

12. Predictive Value of Combining the Ankle-Brachial Index and SYNTAX Score for the Prediction of Outcome After Percutaneous Coronary Intervention (from the SHINANO Registry)

Author

Ueki, Yasushi, Miura, Takashi, Miyashita, Yusuke, Motoki, Hirohiko, Shimada, Kentaro, Kobayashi, Masanori, Nakajima, Hiroyuki, Kimura, Hikaru, Akanuma, Hiroshi, Mawatari, Eiichiro, Sato, Toshio, Hotta, Shoji, Kamiyoshi, Yuichi, Maruyama, Takuya, Watanabe, Noboru, Eisawa, Takayuki, Aso, Shinichi, Uchikawa, Shinichiro, Hashizume, Naoto, Sekimura, Noriyuki, Morita, Takehiro, Ebisawa, Soichiro, Izawa, Atsushi, Koyama, Jun, and Ikeda, Uichi

Published
2016
Full Text
View/download PDF

19. Comparison of mid-term outcomes between patients with and without atrial fibrillation undergoing coronary stenting in the second-generation drug-eluting stent era: from the SHINANO registry

Author

Miura, Takashi, Miyashita, Yusuke, Motoki, Hirohiko, Kobayashi, Hideki, Kobayashi, Masanori, Nakajima, Hiroyuki, Kimura, Hikaru, Akanuma, Hiroshi, Mawatari, Eiichiro, Sato, Toshio, Hotta, Shoji, Kamiyoshi, Yuichi, Maruyama, Takuya, Watanabe, Noboru, Eizawa, Takayuki, Aso, Shinichi, Uchikawa, Shinichiro, Hashizume, Naoto, Senda, Keisuke, Morita, Takehiro, Ebisawa, Soichiro, Izawa, Atsushi, Koyama, Jun, and Ikeda, Uichi

Published
2017
Full Text
View/download PDF

21. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with prior heart failure undergoing percutaneous coronary intervention: sub-analysis of the SHINANO registry

Author

Minamisawa, Masatoshi, Miura, Takashi, Motoki, Hirohiko, Kobayashi, Hideki, Kobayashi, Masanori, Nakajima, Hiroyuki, Kimura, Hikaru, Akanuma, Hiroshi, Mawatari, Eiichiro, Sato, Toshio, Hotta, Shoji, Kamiyoshi, Yuichi, Maruyama, Takuya, Watanabe, Noboru, Eisawa, Takayuki, Aso, Shinichi, Uchikawa, Shinichiro, Senda, Keisuke, Morita, Takehiro, Hashizume, Naoto, Abe, Naoyuki, Ebisawa, Soichiro, Izawa, Atsushi, Miyashita, Yusuke, Koyama, Jun, Ikeda, Uichi, and On behalf of the SHINANO Registry Investigators

Published
2017
Full Text
View/download PDF

22. Prognostic value of ankle brachial index for future incident heart failure in patients without previous heart failure: data from the impressive predictive value of ankle brachial index for clinical long term outcome in patients with cardiovascular disease examined by ABI study

Author

Nishimura, Hitoshi, Miura, Takashi, Minamisawa, Masatoshi, Ueki, Yasushi, Abe, Naoyuki, Hashizume, Naoto, Mochidome, Tomoaki, Harada, Mikiko, Shimizu, Kunihiko, Shoin, Wataru, Yoshie, Koji, Oguchi, Yasutaka, Ebisawa, Soichiro, Motoki, Hirohiko, Izawa, Atsushi, Koyama, Jun, and Ikeda, Uichi

Published
2017
Full Text
View/download PDF

26. Abstract 17741: Prognostic Value of Ankle-Brachial Index for Future Amputation and Critical Limb Ischemia in Patients With Peripheral Artery Disease

Author

Nomi, Hidetomo, Nishimura, Hitoshi, Miura, Takashi, Minamisawa, Masatoshi, Ueki, Yasushi, Abe, Naoyuki, Hashizume, Naoto, Mochidome, Tomoaki, Harada, Mikiko, Shimizu, Kunihiro, Shoin, Wataru, Yoshie, Koji, Oguchi, Yasutaka, Saigusa, Tatsuya, Ebisawa, Soichiro, Motoki, Hirohiko, Izawa, Atsushi, Koyama, Jun, Ikeda, Uichi, and Kuwahara, Koichiro

Published
2017

30. Efficacy and Safety of Percutaneous Coronary Intervention for Elderly Patients in the Second-Generation Drug-Eluting Stent Era: The SHINANO Registry

Author

Miura, Takashi, Miyashita, Yusuke, Motoki, Hirohiko, Kobayashi, Hideki, Kobayashi, Masanori, Nakajima, Hiroyuki, Kimura, Hikaru, Akanuma, Hiroshi, Mawatari, Eiichiro, Sato, Toshio, Hotta, Shoji, Kamiyoshi, Yuichi, Maruyama, Takuya, Watanabe, Noboru, Eisawa, Takayuki, Aso, Shinichi, Hashizume, Naoto, Ebisawa, Soichiro, and Ikeda, Uichi

Published
2017
Full Text
View/download PDF

34. Impact of Flood Due to Typhoon Hagibis on Cardiovascular and Cerebrovascular Events in the Disaster Area of Nagano City: A Sub-Analysis Using Data From the SAVE Trial

Author

Komatsu, Toshinori, primary, Miura, Takashi, additional, Sunohara, Daisuke, additional, Yahikozawa, Kumiko, additional, Momose, Tomoyasu, additional, Kouno, Tunesuke, additional, Motoki, Hirohiko, additional, Mochidome, Tomoaki, additional, Kasai, Toshio, additional, Kuwahara, Koichiro, additional, and Ikeda, Uichi, additional

Published
2022
Full Text
View/download PDF

37. Relationship between the flood disaster caused by the Reiwa first year east Japan typhoon and cardiovascular and cerebrovascular events in Nagano City: The SAVE trial

Author

Sunohara, Daisuke, primary, Miura, Takashi, additional, Komatsu, Toshinori, additional, Hashizume, Naoto, additional, Momose, Tomoyasu, additional, Kono, Tsunesuke, additional, Motoki, Hirohiko, additional, Mochidome, Tomoaki, additional, Kasai, Toshio, additional, Kuwahara, Koichiro, additional, and Ikeda, Uichi, additional

Published
2021
Full Text
View/download PDF

38. Effect of Standard vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke A Randomized Clinical Trial and Meta-analysis

Author

Kitagawa Kazuo, Yamamoto Yasumasa, Arima Hisatomi, Maeda Toshiki, Sunami Norio, Kanzawa Takao, Eguchi Kazuo, Kamiyama Kenji, Minematsu Kazuo, Ueda Shinichiro, Rakugi Hiromi, Ohya Yusuke, Kohro Takahide, Yonemoto Koji, Okada Yasushi, Higaki Jitsuo, Tanahashi Norio, Kimura Genjiro, Umemura Satoshi, Matsumoto Masayasu, Shimamoto Kazuaki, Ito Sadayoshi, Saruta Takao, Shimada Kazuyuki, Kario Kazuomi, Saito Yoshihiko, Terayama Yasuo, Toyoda Kazunori, Okura Takafumi, Hoshino Haruhiko, Makino Hirofumi, Uchida Haruhito, Uchiyama Shinichiro, Etani Hideki, Kohriyama Tatsuo, Tomimoto Hidekazu, Yoshio Taku, Kobayashi , Shotai, Usami Hiroko, Iihoshi Satoshi, Mikami Takeshi, Mikuni Nobuhiro, Miyata Kei, Murakami Tomohiro, Endo Hideki, Fukui Takahito, Fumoto Kentaro, Hara Keiji, Honjo Kaori, Kinoshita Yusuke, Maeda Masana, Mikamoto Masaaki, Mori Daisuke, Murahashi Takeo, Nomura Ryota, Noro Shusaku, Ogino Tatsuya, Okuma Masahiro, Otake Yasuhumi, Shindo Koichiro, Sugio Hironori, Takada Hidekazu, Takahira Kazuki, Takeuchi Akiko, Watanabe Toshiichi, Yamaguchi Yohei, Abumiya Takeo, Houkin Kiyohiro, Matsumura Shigeki, Shinohe Rikiya, Kuroshima Kiyomi, Takizawa Katsumi, Yoshida Kazuto, Morimoto Hideo, Hasebe Naoyuki, Koyama Satoshi, Maruyama Junichi, Irie Shinsuke, Nakano Takahiro, Ogasawara Yukari, Ohkuma Hiroki, Shibanai Kazuo, Hikichi Kentaro, Kobayashi Shinya, Moroi Junta, Nakase Taizen, Okada Takeshi, Takano Daiki, Takenaka Shunsuke, Yoshioka Shotaro, Yanagisawa Toshiharu, Hirata Yutaka, Konno Shu, Sato Tomohiko, Ito Miiko, Kondo Rei, Mori Wataru, Saito Shinjiro, Kokubo Yasuaki, Kato Hideaki, Oyama Hideki, Matsuo Kaneyuki, Matsumoto Masahiro, Nakamura Mari, Koizumi Takayuki, Sato Hiroyuki, Shibata Yasushi, Hashimoto Masaaki, Kurita Hideharu, Matsumoto Eiji, Ishiguro Koji, Asakura Ken, Fujimaki Hiroya, Wakabayashi Kazuki, Akaji Kazunori, Horikoshi Tomo, Kano Tadashige, Katano Takehiro, Kimura Hiroaki, Mihara Ban, Suzuki Kentaro, Takayama Yohei, Ishii Akira, Momomura Sin-ichi, Sugawara Hitoshi, Yamashita Takeshi, Kaneko Uichi, Takahashi Toshie, Arai Toshinari, Tanaka Yoshihiro, Inokuma Shigehisa, Kato Yuji, Ishige Naoki, Muramatsu Kazuhiro, Nogawa Shigeru, Yoshizaki Takahito, Ohashi Takashi, Suda Sumio, Iguchi Yasuyuki, Mitsumura Hidetaka, Adachi Tomohide, Konoeda Fumie, Oki Koichi, Tanaka Ryota, Urabe Takao, Yamashiro Kazuo, Ito Akihiro, Nakatomi Hirofumi, Shojima Masaaki, Otsuka Kuniaki, Shibata Koichi, Abe Takato, Itoh Yoshiaki, Suzuki Norihiro, Toi Sono, Teramoto Tamio, Fukunaga Atsushi, Kujuro Yuki, Ohta Kouichi, Osada Takashi, Shimizu Katuyoshi, Kitagawa Yasuhisa, Tokuoka Kentaro, Omura Masao, Kikyo Hideyuki, Kamide Tomoya, Kitamura Yoshihisa, Miyashita Katsuyoshi, Mori Kentaro, Shima Hiroshi, Tamase Akira, Akutsu Tsugio, Nishiyama Kazutoshi, Takizawa Shunya, Uesugi Tsuyoshi, Ikeda Uichi, Koshikawa Megumi, Yamasaki Saeko, Inoue Atsushi, Matsumoto Yasuko, Yamaguchi Kazuyoshi, Hirose Genjirou, Kontani Satoshi, Takasawa Kazuya, Hirahara Katsumi, Kodama Makoto, Yagihara Nobue, Hata Takashi, Hori Makoto, Oda Rokuhei, Kubo Ayuka, Okuda Satoshi, Yamada Kentaro, Takeuchi Hiroki, Araki Yoshio, Ito Mizuki, Senda Joe, Wakabayashi Toshihiko, Ito Shinji, Mutoh Tatsuro, Kawase Yukinori, Ando Fumio, Okamoto Shinya, Shimada Takuya, Shindo Akihiro, Nishikawa Masakatsu, Niwa Atsushi, Sasaki Ryogen, Murata Hiroto, Yata Kenichiro, Matsuo Koushun, Yagi Hideo, Shiogai Toshiyuki, Nagakane Yoshinari, Fujinami Jun, Nakagawa Masanori, Ohara Ryo, Tomii Yasuhiro, Arakawa Yoshiki, Funaki Takeshi, Ihara Masafumi, Kitamura Akihiro, Maki Takakuni, Miyamoto Susumu, Nakaya Yoshifumi, Takahashi Ryosuke, Takenobu Yohei, Yoshida Kazumichi, Ino Tadashi, Murase Nagako, Ohotani Ryo, Kawashima Atsushi, Watanabe Akiko, Hayashi Yuko, Ohmichi Takuma, Yasuda Rei, Yoshioka Akira, Yuki Natsuko, Makino Masahiro, Yamaguchi Tatsuyuki, Matsuzaki Jyo, Niki Hitoshi, Shiraishi Shoichi, Yanagihara Takehiko, Yamada Keiichi, Hatate Jun, Miwa Kaori, Okazaki Shuhei, Arihiro Shoji, Doijiri Ryosuke, Higashida Kyoko, Kajimoto Katsufumi, Miyashita Kotaro, Nagatsuka Kazuyuki, Saito Kozue, Sugiura Yuri, Takizawa Hotake, Torii Takako, Yokota Chiaki, Kajimoto Yoshinaga, Kuroiwa Toshihiko, Fukunaga Ryuzo, Takahashi Tsutomu, Nakao Kazutami, Kajiyama Yuta, Kimura Yasuyoshi, Naka Takashi, Otomune Hironori, Tanahashi Takao, Uehara Takuya, Hashimoto Hiroyuki, Uematsu Toshihiko, Kataoka Kazuo, Okayama Satoshi, Somekawa Satoshi, Yamada Shuichi, Sasaki Rie, Yamano Shigeru, Nakao Naoyuki, Obayashi Shinji, Hamaguchi Hirotoshi, Toda Tatsushi, Washida Kazuo, Hoshi Taku, Kono Tomoyuki, Sekiya Hiroaki, Sugo Norifumi, Todo Kenichi, Togo Masaya, Yamagami Hiroshi, Yamamoto Shiro, Shiro Yoshihiko, Takaoka Toshio, Abe Satoshi, Hamada Chizuko, Ishihara Masaki, Kadota Katuhiko, Nakagawa Tomonori, Oguro Hiroaki, Takayoshi Hiroyuki, Yamaguchi Takuya, Yamaguchi , Shuuhei, Mizuhara Ryo, Okada Kazunori, Yamagata Shingo, Sasaki Akira, Abe Koji, Deguchi Kentaro, Deguchi Shoko, Nakano Yumiko, Hirai Satoshi, Uno Masaaki, Yokosuka Kimihiko, Manabe Yasuhiro, Ito Hijiri, Aoki Shiro, Hosomi Naohisa, Kihara Yasuki, Kisaka Tomohiko, Maruyama Hirofumi, Araki Hayato, Ogami Ryo, Torii Tsuyoshi, Yokoyama Noboru, Yokoyama Takakazu, Kataoka Satoshi, Kitamura Takeshi, Kanda Takashi, Maeda Toshihiko, Shimizu Fumitaka, Seki Kozaburo, Bando Yuko, Ohara Masaki, Yamasaki Masahiro, Masahira Noritaka, Ueba Tetsuya, Ueba Yusuke, Fujimoto Yuichi, Haro Keiko, Ogata Hidenori, Shida Norihiko, Matsumoto Takeshi, Okamoto Kensho, Kawamoto Ryuichi, Arakawa Shuji, Shii Hirofumi, Kanai Hidetoshi, Fujimoto Shigeru, Jinnouchi Juro, Matsuki Takayuki, Osaki Masato, Arakawa Kimika, Ibaraki Ai, Kiyohara Kanako, Ohta Yuko, Oniki Hideyuki, Sakaki Minako, Tominaga Mitsuhiro, Tsuchihashi Takuya, Higashi Saho, Ishikawa Hiromi, Ishitsuka Koji, Kitayama Jiro, Nakane Hiroshi, Yoshimura Takeo, Kakino Shunsuke, Kaneko Yoshirou, Inoue Junnosuke, Maruyama Yoshikazu, Isa Katsunori, Sakima Hirokuni, and Nakada Seigo

Subjects
medicine.medical_specialty, education.field_of_study, business.industry, Standard treatment, Population, medicine.disease, law.invention, 03 medical and health sciences, 0302 clinical medicine, Blood pressure, Randomized controlled trial, law, Relative risk, Internal medicine, Multicenter trial, Number needed to treat, Medicine, 030212 general & internal medicine, Neurology (clinical), business, education, Stroke, 030217 neurology & neurosurgery, Original Investigation
Abstract

Importance The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated that a systolic blood pressure (BP) target less than 120 mm Hg was superior to less than 140 mm Hg for preventing vascular events. This trial excluded patients with prior stroke; therefore, the ideal BP target for secondary stroke prevention remains unknown. Objective To assess whether intensive BP control would achieve fewer recurrent strokes vs standard BP control. Design, Setting, and Participants Randomized clinical trial (RCT) of standard vs intensive BP control in an intent-to-treat population of patients who had a history of stroke. Patients were enrolled between October 20, 2010, and December 7, 2016. For an updated meta-analysis, PubMed and the Cochrane Central Library database were searched through September 30, 2018, using the Medical Subject Headings and relevant search terms forcerebrovascular diseaseand forintensive BP lowering. This was a multicenter trial that included 140 hospitals in Japan; 1514 patients who had a history of stroke within the previous 3 years were approached, but 234 refused to give informed consent. Interventions In total, 1280 patients were randomized 1:1 to BP control to less than 140/90 mm Hg (standard treatment) (n = 640) or to less than 120/80 mm Hg (intensive treatment) (n = 640). However, 17 patients never received intervention; therefore, 1263 patients assigned to standard treatment (n = 630) or intensive treatment (n = 633) were analyzed. Main Outcomes and Measures The primary outcome was stroke recurrence. Results The trial was stopped early. Among 1263 analyzed patients (mean [SD] age, 67.2 [8.8] years; 69.4% male), 1257 of 1263 (99.5%) completed a mean (SD) of 3.9 (1.5) years of follow-up. The mean BP at baseline was 145.4/83.6 mm Hg. Throughout the overall follow-up period, the mean BP was 133.2/77.7 (95% CI, 132.5-133.8/77.1-78.4) mm Hg in the standard group and 126.7/77.4 (95% CI, 125.9-127.2/73.8-75.0) mm Hg in the intensive group. Ninety-one first recurrent strokes occurred. Nonsignificant rate reductions were seen for recurrent stroke in the intensive group compared with the standard group (hazard ratio [HR], 0.73; 95% CI, 0.49-1.11;P = .15). When this finding was pooled in 3 previous relevant RCTs in a meta-analysis, the risk ratio favored intensive BP control (relative risk, 0.78; 95% CI, 0.64-0.96;P = .02; absolute risk difference, −1.5%; 95% CI, −2.6% to −0.4%; number needed to treat, 67; 95% CI, 39-250). Conclusions and Relevance Intensive BP lowering tended to reduce stroke recurrence. The updated meta-analysis supports a target BP less than 130/80 mm Hg in secondary stroke prevention. Trial Registration ClinicalTrials.gov identifier:NCT01198496

Published
2019

49. Cilostazol effectiveness in reducing drug-coated stent restenosis in the superficial femoral artery: The ZERO study.

Author

Miura, Takashi, Miyashita, Yusuke, Hozawa, Koji, Doijiri, Tatsuki, Kato, Tamon, Hayakawa, Naoki, Hashizume, Naoto, Nakano, Masatsugu, Ikeda, Uichi, and Kuwahara, Koichiro

Subjects
FEMORAL artery, DRUG-eluting stents, PERIPHERAL vascular diseases, ENDOVASCULAR surgery, MEDICAL ethics committees
Abstract

Purpose: Drug-eluting stents (DESs) play an important role in endovascular therapy (EVT) for femoropopliteal (FP) lesions. Cilostazol improves patency after bare-metal nitinol stent (BNS) implantation for femoropopliteal lesions. This study aimed to establish whether cilostazol is effective in improving the patency of DESs and determine whether BNS or DESs with or without cilostazol are more effective in improving the 12-month patency after EVT for FP lesions. Materials and methods: In this prospective, open-label, multicenter study, 85 patients with symptomatic peripheral artery disease due to de novo FP lesions were enrolled and treated with DESs with cilostazol from eight cardiovascular centers between April 2018 and May 2019. They were compared with 255 patients from the DEBATE SFA study, in which patients were randomly assigned to the BNS, BNS with cilostazol, or DES groups. The primary endpoint was the 12-month patency rate using duplex ultrasound (peak systolic velocity ratio < 2.5). This study was approved by the ethics committee of each hospital. Results: The 12-month patency rates for the BNS, BNS with cilostazol, DES, and DES with cilostazol groups were 77.6%, 93.1%, 82.8%, and 94.2%, respectively (p = 0.007). The 12-month patency rate was higher in the DES with cilostazol group than in the DES group (p = 0.044). In small vessels, the DES with cilostazol group had a higher patency rate than the DES group (100.0% vs. 83.4%, p = 0.023). Conclusions: DES with cilostazol showed better patency than DES alone. Cilostazol improved patency after EVT with DES in FP lesions and small vessels. Clinical trial registration: University Hospital Medical Information Network Clinical Trials Registry (no. UMIN 000032473). [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results